Stryker Spine received FDA 510(k) clearance to market Tritanium® TL, a 3D-printed curved posterior lumbar interbody fusion cage. The device will launch in 2Q18.
The hollow implant comprises solid and porous structures that are simultaneously built with AMagine™, Stryker’s proprietary additive manufacturing method. Tritanium highly-porous titanium material is designed to create a favorable environment for osteoblast attachment, and may be able to retain fluid unlike traditional titanium.
Tritanium TL joins other products in Stryker’s 3D-printed spine portfolio, the Tritanium PL Posterior Lumbar Cage and the Tritanium C Anterior Cervical Cage.
Stryker Spine received FDA 510(k) clearance to market Tritanium® TL, a 3D-printed curved posterior lumbar interbody fusion cage. The device will launch in 2Q18.
The hollow implant comprises solid and porous structures that are simultaneously built with AMagine™, Stryker’s proprietary additive manufacturing method. Tritanium highly-porous...
Stryker Spine received FDA 510(k) clearance to market Tritanium® TL, a 3D-printed curved posterior lumbar interbody fusion cage. The device will launch in 2Q18.
The hollow implant comprises solid and porous structures that are simultaneously built with AMagine™, Stryker’s proprietary additive manufacturing method. Tritanium highly-porous titanium material is designed to create a favorable environment for osteoblast attachment, and may be able to retain fluid unlike traditional titanium.
Tritanium TL joins other products in Stryker’s 3D-printed spine portfolio, the Tritanium PL Posterior Lumbar Cage and the Tritanium C Anterior Cervical Cage.
Copy to clipboard 
